Natco Pharma appoints Madhava Rao Karicherla as Associate Vice President - Formulation RnD, Pharma Division, Kothur Unit
Advertisement
Telangana: Natco Pharma has announced that Madhava Rao Karicherla has been appointed as Associate Vice President - Formulation Research & Development, Pharma Division, Kothur Unit w.e.f. 15th November, 2024.
Madhava Rao is an Innovative and Performance driven Pharmaceutical professional with 20 plus years of rich and extensive experience in global Generic product development, ANDA Filings, Project Life Cycle Management, Operations Management, Procurement Strategy, Quality Management, Budgeting, Team Management, and People Management across Pharmaceutical Industry.
He is also having expertise in Pre-formulation and formulation development of Oral Solid Dosage forms (OSD’s) (Immediate release and extended-release tablets, DR capsules), liquid orals and parenteral dosage forms (dry powder injections, lyophilized preparations, liquid injections (aqueous and oily). He is also experienced in designing and implementation of first- to- file patent non-infringing strategies for USA and European markets and exposure to Patents and Patent infringement analysis to design patent non-infringing ANDAs for regulated markets.
Prior to joining with NATCO Pharma Limited, Madhava Rao worked with Sandoz India Private Limited, EugiaPharma Specialities Limited, Stabicon Life Sciences, LaurusLabs Limited, Abdi Ibrahim Pharmaceuticals, AurobindoPharma Limited and Ranbaxy Research Laboratories.
He did Master’s of Pharmacy (Pharmaceutical Technology, Formulations) from National Institute of PharmaceuticalEducation and Research, Mohali, India, 2003 and Bachelor of Pharmacy from Osmania University, India, 2001.
Read also: Natco Pharma names Imtiyaz Basade as Senior Vice President - RAD, Pharma Division, Kothur Unit
Natco Pharma Limited was incorporated in Hyderabad in the year 1981 with an initial investment of INR 3.3 million. With a modest beginning of operations as a single unit with 20 employees, Natco today has eight manufacturing facilities spread across India with modern research laboratories, capabilities in New Drug Development, etc.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.